Status:
UNKNOWN
Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening
Lead Sponsor:
University of Hawaii
Conditions:
HPV
Eligibility:
FEMALE
25+ years
Brief Summary
In this study, the investigators will assess whether implementing a self-swab protocol for primary Human Papilloma Virus (HPV) testing is an effective method to increase cervical cancer screening in a...
Detailed Description
Cervical cancer is the fourth most common cancer worldwide. In the United States, the majority of cervical cancer diagnoses are made in individuals who have not been adequately screened. Cervical canc...
Eligibility Criteria
Inclusion
- Age of 25 years or older
- Have a cervix
- Have an indication for cervical cancer screening per Accreditation Council for Continuing Medical Education (ASCCP) guidelines
- Have been previously referred to women's health in the past 5 years or subjects have declined a women's health referral.
- Subjects must not have been seen in women's health clinic since referral was placed
Exclusion
- Subjects unable to consent in one of the following languages: English, Chuukese, or Marshallese
- Subjects with known history of cervical cancer
- Subjects that are currently pregnant or within 3 months of giving birth
Key Trial Info
Start Date :
August 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05989464
Start Date
August 8 2023
End Date
February 1 2025
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kalihi Palama
Honolulu, Hawaii, United States, 17460